JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens

Not allCALRmutations are created equal

(2015) Rong He et al.   LEUKEMIA & LYMPHOMA

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

(2014) P. Lundberg et al.   BLOOD

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

(2014) E. Lippert et al.   HAEMATOLOGICA

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

(2009) Damla Olcaydu et al.   NATURE GENETICS